1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays

STUDY GOALS AND OBJECTIVES

BCC’s goal in conducting this study was to determine the current status of the worldwide demand for immunoassays and to assess its growth potential over the five-year period from 2012 to 2017. We were particularly interested in the key industry applications of immunoassay technology in the U.S., Europe, Africa, the Middle East, and Asia. In addition, we were interested in the market potential for key prevailing immunoassay technology applications. Our main objective was to present a comprehensive analysis of the current immunoassay technology markets and its future direction.

REASONS FOR DOING THIS STUDY

Immunoassays represent one of the most used testing methodologies in the world today. Hence, we were interested in determining the different immunoassay applications and examining their growth potential. We also were especially interested in determining the types of technologies currently in use and their specific applications.

BCC has over the past several years examined the biological technology industry. Within this period, Immunoassay technology used in various types of medical and other diagnostics-type applications has taken diverse configurations. As a consequence, the use of this technology is changing with time. Therefore, BCC wanted to conduct a thorough and detailed analysis of immunoassay technology and project its growth potential.

CONTRIBUTIONS TO THE STUDY AND FOR WHOM

We have compiled a study of current immunoassay testing procedures markets and new emerging immunoassay technology markets. We present the economic environment of the immunoassay examination industry, technological descriptions and issues, applications, market factors, and potential, and project growth trends for the period of year 2012 to 2017. We also project market values and the distribution of immunoassay testing applications by the major market segments. This study will be of interest to the medical laboratory, in vitrodiagnostics, biotechnologies, medical diagnostic products, and drug testing industries. It will also be of interest to biological detection device hardware and software developers, manufacturing companies, and distributors.

SCOPE AND FORMAT

The scope of this study encompasses an investigation of the markets for the following immunoassay testing categories: enzyme, fluorescence, radio-immunoassay (RIA), cardiac analysis, infectious diseases, and tumor diagnosis. BCC analyzes each immunoassay examination type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues including the latest trends are discussed. BCC analyzes the industry on a worldwide basis, both from an application and demand point of view in the major regions of the world.

METHODOLOGY

BCC presents an analysis of each diagnostic application type and its estimated demand in 2012. Our estimated values are based on how much buying entities can be expected to pay in un-depreciated dollars. We then analyzed the potential applications for each usage in the field of immunoassay testing, and forecast the market size for 2012 and 2017. We also analyzed the demand for immunoassay analysis by major geographical market segments. All tables and figures are calculated in 2012 constant U.S. dollars.

INFORMATION SOURCES

BCC analyzed data produced by U.S. government agencies, industry trade associations, and international organizations to obtain data for this study. We also spoke with manufacturers of various immunoassay technology types in the U.S., the European Union, and Japan. In addition, we compiled data from current financial and trade information sources.

REPORT HIGHLIGHTS

This report provides:
• An examination of the growth of immunoassay technology in clinical, food safety, and environmental areas; this report focuses on Infectious disease immunoassays
• Analysis of global market trends, with data provided for 2011 and 2012, and projections, with five-year compound annual growth rates (CAGRs), through 2017
• Discussion of government regulations and technology patents and the roles they play in development
• Analysis of new markets
• Comprehensive company profiles of major players.

Table Of Contents

Immunoassays: Technologies and Global Markets -- Focus on Infectious Disease Immunoassays
TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2

STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
CONTRIBUTIONS TO THE STUDY AND FOR WHOM 2
SCOPE AND FORMAT 3
METHODOLOGY 3
INFORMATION SOURCES 3
RELATED REPORTS 3
BCC ONLINE SERVICES 3
DISCLAIMER 4

CHAPTER 2 SUMMARY 6

SUMMARY TABLE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, THROUGH
2017 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, 2011-2017
($ MILLIONS) 7

CHAPTER 3 OVERVIEW 9

IMMUNOASSAYS 9
ENZYME IMMUNOASSAYS 10
TABLE 1 ADVANTAGES OF ENZYME IMMUNOASSAY 10
TABLE 2 LIMITATIONS OF ENZYME IMMUNOASSAY 11
FLUORESCENT IMMUNOASSAYS 11
TABLE 3 ADVANTAGES OF FLUORESCENT IMMUNOASSAY 11
TABLE 4 LIMITATIONS OF FLUORESCENT IMMUNOASSAY 12
IMMUNOASSAY TECHNOLOGIES 12
DISPOSABLE MATRIX DEVICES 13
Handheld Immunochromatographic Assays (HHAs) 13
BTA Test Strips 13
Sensitive Membrane Antigen Rapid Test (SMART) 13
REAGENT TAG BIOSENSOR APPROACHES 14
NO-TAG REAGENT BIOSENSOR METHODS 14
RADIOISOTOPES 15
TABLE 5 ADVANTAGES OF RADIOISOTOPES 15
TABLE 6 LIMITATIONS OF RADIOISOTOPES 15

CHAPTER 4 GLOBAL TRENDS IMPACTING DEMAND FOR IMMUNOASSAY TESTING 18

MEDICAL AND RESEARCH LABORATORY SUPPLIES INDUSTRY TRENDS 18
DEMOGRAPHIC CHANGE 18
THE MAJOR U.S. COMPETITORS 19
GLOBAL DEMAND TRENDS 19
TABLE 7 GLOBAL MEDICAL PRODUCTS MARKET, 2012-2017 ($ BILLIONS) 19
INDUSTRY TRADE OBSTACLES AND OPPORTUNITIES 20
DRUG TESTING TRENDS 20

CHAPTER 5 THE GLOBAL MARKET 22

WORLD DEMAND FOR IMMUNOASSAYS 22
EUROPEAN DEMAND FOR IMMUNOASSAYS 22
TABLE 8 WESTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRY
THROUGH 2017 ($ MILLIONS) 22
TABLE 9 EASTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 25
ASIAN DEMAND FOR IMMUNOASSAYS 26
TABLE 10 ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($
MILLIONS) 26
TABLE 11 OCEANIA DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017
($ MILLIONS) 27
TABLE 12 SOUTHEAST ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 28
THE AMERICAS' DEMAND FOR IMMUNOASSAYS 29
TABLE 13 NORTH AMERICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 29
TABLE 14 CENTRAL AND SOUTH AMERICAN DEMAND FOR IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 30
AFRICAN DEMAND FOR IMMUNOASSAYS 31
TABLE 15 NORTH AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH
2017 ($ MILLIONS) 31
SUB-SAHARAN AFRICAN DEMAND FOR IMMUNOASSAYS 32
TABLE 16 SUB-SAHARAN AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 32
MIDDLE EASTERN DEMAND FOR IMMUNOASSAYS 33
TABLE 17 MIDDLE EASTERN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 34

CHAPTER 6 INFECTIOUS DISEASE IMMUNOASSAYS 37

TABLE 18 GLOBAL DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY REGION,
THROUGH 2017 ($ MILLIONS) 37
EUROPEAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 38
TABLE 19 WESTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASE
IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 38
TABLE 20 EASTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASE
IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 39
ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 40
TABLE 21 ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 40
TABLE 22 OCEANIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 41
TABLE 23 SOUTHEAST ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS
BY COUNTRY, THROUGH 2017 ($ MILLIONS) 41
THE AMERICAS' DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 42
TABLE 24 NORTH AMERICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS
BY COUNTRY, THROUGH 2017 ($ MILLIONS) 42
TABLE 25 CENTRAL AND SOUTH AMERICAN DEMAND FOR INFECTIOUS DISEASE
IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 43
AFRICA DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 43
TABLE 26 NORTH AFRICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 44
TABLE 27 SUBSARAHAN AFRICAN DEMAND FOR INFECTIOUS DISEASE
IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 45
MIDDLE EASTERN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS 46
TABLE 28 MIDDLE EASTERN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS
BY COUNTRY, THROUGH 2017 ($ MILLIONS) 46

CHAPTER 7 COMPANY PROFILES 49

TABLE 29 RANKING OF LEADING IMMUNOASSAY TECHNOLOGY MANUFACTURERS 49
ABBOTT DIAGNOSTICS 49
ACON LABORATORIES INC. 50
AMAR IMMUNODIAGNOSTICS 50
BAYER AG 51
BECKMAN COULTER INC. 51
HISTORY OF BECKMAN COULTER MANUAL IMMUNOASSAYS 51
IMMUNOTECH 52
DIAGNOSTIC SYSTEMS LABORATORIES (DSL) 52
BECKMAN COULTER MANUAL IMMUNOASSAYS TODAY 52
BECTON DICKENSON 53
BEIJING WANGER BIOTECHNOLOGY CO. LTD. 53
BHAT BIO-TECH INDIA PRIVATE LTD. 54
BIOO SCIENTIFIC CORP. 54
BIOVENDOR, LLC 54
RESEARCH and DIAGNOSTIC PRODUCTS DIVISION 55
LABORATORY MEDICINE DIVISION 55
CLINICAL PRODUCTS DIVISION 55
PROFESSIONAL CONSULTATION SERVICES 56
BIOMERIEUX SA 56
CANDOR BIOSCIENCE GMBH 56
CAYMAN CHEMICAL CO. 57
DIAMOND DIAGNOSTICS INC. 58
DIASOURCE IMMUNOASSAYS S.A. 58
IBL INTERNATIONAL GMBH 59
IMMUNOCHEMISTRY TECHNOLOGIES LLC 60
HISTORY 60
PRODUCTS, SERVICES, AND RESEARCH 60
IMMUNOSHOP INDIA PVT LTD. 61
INSTITUTE OF ISOTOPES CO. LTD 61
INSTRUMENTATION LABORATORY CO. 62
NOVARTIS VACCINES and DIAGNOSTICS INC. 62
JEI DANIEL BIOTECH CORP. 63
LABOR DIAGNOSTIKA NORD GMBH and CO. KG 63
MICROPOINT BIOSCIENCE INC. 64
ORTHO CLINICAL DIAGNOSTICS 65
PANTEX 65
PROMEGA CORP. 65
QQLAB LLC 66
QUIDEL CORP. 66
RADIOMETER GMBH 68
ROCHE DIAGNOSTICS CORP. 69
SIEMENS HEALTHCARE 69
SYSMEX 69
TRINITY BIOTECH PLC 70
WEIFANG 3V BIOENGINEERING GROUP CO. LTD. 71
WEIFANG KANGHUA BIOTECH CO. LTD. 71
XIAMEN BOSON BIOTECH CO. LTD. 72
ZHEJIANG ZHUJI BETAI BIOTECHNOLOGY CO. LTD. 73

CHAPTER 8 PATENT ANALYSIS 75

INTRODUCTION 75
GLOBAL PATENT TRENDS 75
TABLE 30 GLOBAL PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 75
TABLE 31 GLOBAL PATENT SHARES BY ASSIGNEE 76
U.S. PATENT TRENDS 80
TABLE 32 U.S. PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OF
PATENTS/%) 80
TABLE 33 U.S. PATENT SHARES BY TECHNOLOGY, 2000-2012 81
U.S. PATENT SHARES BY ASSIGNEE 81
TABLE 34 U .S. PATENT SHARES BY ASSIGNEE 2000-2012 81
SAMPLE ABSTRACTS OF U.S. PATENT ABSTRACTS 82
AUTOANTIBODY-ENHANCED IMMUNOASSAYS AND KITS 82
FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL
TOXIN ACTIVITY 82
CHEMILUMINESCENT COMPOSITIONS FOR USE IN DETECTION OF MULTIPLE
ANALYTES 83
U.S. REGISTERED PATENTS 83
TABLE 35 SAMPLE OF U.S. IMMUNOASSAY PATENTS, 2000-2012 84
EUROPEAN PATENT TRENDS 84
TABLE 36 EUROPEAN PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OF
PATENTS/%) 84
TABLE 37 EUROPEAN PATENT SHARES BY TECHNOLOGY, 2000-2012 85
EUROPEAN PATENT SHARES BY PATENT HOLDER 85
TABLE 38 EUROPEAN PATENT SHARES BY APPLICATION, 2000-2012 86
SAMPLE ABSTRACTS OF EUROPEAN PATENT ABSTRACTS 87
IMMUNOASSAY PRODUCT AND PROCESS 87
ENZYME IMMUNOASSAY MEMBRANE STRIP WITH CRITICAL VALUE LINE
AND INTERPRETATION METHOD THEREOF 88
FLUORESCENCE IMMUNOASSAY METHOD OF USING ZINC OXIDE QUANTUM
DOTS TO MARK ANTIBODY 88
EUROPEAN REGISTERED PATENTS 88
TABLE 39 SAMPLE OF EUROPEAN IMMUNOASSAY PATENTS, 2000-2012 89
JAPANESE PATENT TRENDS 89
TABLE 40 JAPANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 90
TABLE 41 JAPANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 90
JAPANESE PATENT SHARES BY ASSIGNEE 90
TABLE 42 JAPANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF
PATENTS/%) 90
SAMPLE ABSTRACTS OF JAPANESE PATENT ABSTRACTS 91
ENZYME IMMUNOASSAY USING ENZYME LABELED ANTIBODY 91
FLUORESCENCE IMMUNOASSAY 92
FLUORESCENT POLYMER MICROPARTICLE, ITS PRODUCTION, AND
REAGENT AND METHOD FOR FLUORO IMMUNOASSAY UTILIZING THE SAME 92
JAPANESE PATENT REGISTERED PATENTS 93
TABLE 43 SAMPLE OF JAPANESE IMMUNOASSAY PATENTS, 2000-2012 93
CHINESE PATENT TRENDS 93
TABLE 44 CHINESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 94
TABLE 45 CHINESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 94
CHINESE PATENT SHARES BY HOLDER 95
TABLE 46 CHINESE PATENT SHARES BY PATENT HOLDER, 2000-2012 (NO. OF
PATENTS/%) 95
SAMPLE ABSTRACTS OF CHINESE PATENT ABSTRACTS 96
IMMUNOASSAY AND DIAGNOSTIC REAGENT FOR MALARIA 96
ENZYME IMMUNOASSAY KIT FOR COXSACKIE VIRUS B ANTIGEN AND ITS
PREPARING PROCESS 97
VISUAL FLUORESCENCE IMMUNOASSAY METHOD FOR DETERMINING
BIOLOGICAL ACTIVE SUBSTANCE 97
CHINESE PATENTS 97
TABLE 47 SAMPLE OF CHINESE IMMUNOASSAY PATENTS, 2000-2012 98
TAIWANESE PATENT TRENDS 98
TABLE 48 TAIWANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 99
TABLE 49 TAIWANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 99
TABLE 50 TAIWANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF
PATENTS/%) 100
SAMPLE ABSTRACTS OF TAIWAN PATENTS 100
IMMUNOASSAY METHOD FOR DETERMINING GLYCOSYLATED PROTEIN AND
TEST LIQUID THEREOF 100
CARRIER-ENZYME-PROTEIN COMPLEX AND IMMUNOASSAY KIT
COMPRISING THE SAME 100
TAIWANESE REGISTERED PATENTS 101
TABLE 51 SAMPLE OF TAIWANESE IMMUNOASSAY PATENTS, 2000-2012 101
SOUTH KOREA PATENT TRENDS 101
TABLE 52 SOUTH KOREAN PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO.
OF PATENTS/%) 102
TABLE 53 SOUTH KOREAN PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 102
TABLE 54 SOUTH KOREAN PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF
PATENTS/%) 103
SAMPLE ABSTRACTS OF SOUTH KOREAN PATENTS 104
IMMUNOASSAY METHOD USING MEASUREMENT VALUE LOWERING
INHIBITOR FOR IMMUNOASSAY METHOD 104
METHOD OF IMMUNOASSAY FOR THE DETECTION OF TEICOPLANIN 104
IMMUNOASSAY DEVICE FOR ASSAYING WHOLE BLOOD AND
IMMUNOASSAY METHOD USING THE SAME 105
SOUTH KOREAN REGISTERED PATENTS 105
TABLE 55 SAMPLE OF SOUTH KOREAN IMMUNOASSAY PATENTS,2000-2012 106



LIST OF TABLES

SUMMARY TABLE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, THROUGH
2017 ($ MILLIONS) 7
TABLE 1 ADVANTAGES OF ENZYME IMMUNOASSAY 10
TABLE 2 LIMITATIONS OF ENZYME IMMUNOASSAY 11
TABLE 3 ADVANTAGES OF FLUORESCENT IMMUNOASSAY 11
TABLE 4 LIMITATIONS OF FLUORESCENT IMMUNOASSAY 12
TABLE 5 ADVANTAGES OF RADIOISOTOPES 15
TABLE 6 LIMITATIONS OF RADIOISOTOPES 15
TABLE 7 GLOBAL MEDICAL PRODUCTS MARKET, 2012-2017 ($ BILLIONS) 19
TABLE 8 WESTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRY
THROUGH 2017 ($ MILLIONS) 22
TABLE 9 EASTERN EUROPEAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 25
TABLE 10 ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($
MILLIONS) 26
TABLE 11 OCEANIA DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($
MILLIONS) 27
TABLE 12 SOUTHEAST ASIAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 28
TABLE 13 NORTH AMERICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 29
TABLE 14 CENTRAL AND SOUTH AMERICAN DEMAND FOR IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 30
TABLE 15 NORTH AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH
2017 ($ MILLIONS) 31
TABLE 16 SUB-SAHARAN AFRICAN DEMAND FOR IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 32
TABLE 17 MIDDLE EASTERN DEMAND FOR IMMUNOASSAYS BY COUNTRY, THROUGH
2017 ($ MILLIONS) 34
TABLE 18 GLOBAL DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY REGION,
THROUGH 2017 ($ MILLIONS) 37
TABLE 19 WESTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS
BY COUNTRY, THROUGH 2017 ($ MILLIONS) 38
TABLE 20 EASTERN EUROPEAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS
BY COUNTRY, THROUGH 2017 ($ MILLIONS) 39
TABLE 21 ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY COUNTRY,
THROUGH 2017 ($ MILLIONS) 40
TABLE 22 OCEANIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 41
TABLE 23 SOUTHEAST ASIAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS
BY COUNTRY, THROUGH 2017 ($ MILLIONS) 41
TABLE 24 NORTH AMERICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 42
TABLE 25 CENTRAL AND SOUTH AMERICAN DEMAND FOR INFECTIOUS DISEASE
IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 43
TABLE 26 NORTH AFRICAN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 44
TABLE 27 SUBSARAHAN AFRICAN DEMAND FOR INFECTIOUS DISEASE
IMMUNOASSAYS BY COUNTRY, THROUGH 2017 ($ MILLIONS) 45
TABLE 28 MIDDLE EASTERN DEMAND FOR INFECTIOUS DISEASE IMMUNOASSAYS BY
COUNTRY, THROUGH 2017 ($ MILLIONS) 46
TABLE 29 RANKING OF LEADING IMMUNOASSAY TECHNOLOGY MANUFACTURERS 49
TABLE 30 GLOBAL PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 75
TABLE 31 GLOBAL PATENT SHARES BY ASSIGNEE 76
TABLE 32 U.S. PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OF
PATENTS/%) 80
TABLE 33 U.S. PATENT SHARES BY TECHNOLOGY, 2000-2012 81
TABLE 34 U .S. PATENT SHARES BY ASSIGNEE 2000-2012 81
TABLE 35 SAMPLE OF U.S. IMMUNOASSAY PATENTS, 2000-2012 84
TABLE 36 EUROPEAN PATENT GENERATION TRENDS BY YEARS, 2000-2012 (NO. OF
PATENTS/%) 84
TABLE 37 EUROPEAN PATENT SHARES BY TECHNOLOGY, 2000-2012 85
TABLE 38 EUROPEAN PATENT SHARES BY APPLICATION, 2000-2012 86
TABLE 39 SAMPLE OF EUROPEAN IMMUNOASSAY PATENTS, 2000-2012 89
TABLE 40 JAPANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 90
TABLE 41 JAPANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 90
TABLE 42 JAPANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF PATENTS/%) 90
TABLE 43 SAMPLE OF JAPANESE IMMUNOASSAY PATENTS, 2000-2012 93
TABLE 44 CHINESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 94
TABLE 45 CHINESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 94
TABLE 46 CHINESE PATENT SHARES BY PATENT HOLDER, 2000-2012 (NO. OF
PATENTS/%) 95
TABLE 47 SAMPLE OF CHINESE IMMUNOASSAY PATENTS, 2000-2012 98
TABLE 48 TAIWANESE PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO. OF
PATENTS/%) 99
TABLE 49 TAIWANESE PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 99
TABLE 50 TAIWANESE PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF
PATENTS/%) 100
TABLE 51 SAMPLE OF TAIWANESE IMMUNOASSAY PATENTS, 2000-2012 101
TABLE 52 SOUTH KOREAN PATENT GENERATION TRENDS BY YEAR, 2000-2012 (NO.
OF PATENTS/%) 102
TABLE 53 SOUTH KOREAN PATENT SHARES BY TECHNOLOGY, 2000-2012 (NO. OF
PATENTS/%) 102
TABLE 54 SOUTH KOREAN PATENT SHARES BY ASSIGNEE, 2000-2012 (NO. OF
PATENTS/%) 103
TABLE 55 SAMPLE OF SOUTH KOREAN IMMUNOASSAY PATENTS,2000-2012 106



LIST OF FIGURES

SUMMARY FIGURE GLOBAL DEMAND FOR IMMUNOASSAYS BY REGION, 2011-2017 ($
MILLIONS) 7

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

US Coagulation Testing Market: Hospitals, Commercial Laboratories, POC Locations

  • $ 7500
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500. Summary This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.